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Background: Depressive symptoms are more common in adults with diabetes and may arise from the physical and
psychosocial burden of disease. Better quality of diabetes care may be associated with a reduced disease burden
and fewer depressive symptoms. Methods: This cross-sectional study included 34 420 participants from
19 countries in the European Social Survey Round 7 (2014–2015). Countries were grouped into quartiles based
on their quality of diabetes care as measured in the Euro Diabetes Index 2014. Individual-level depressive
symptoms were measured using the 8-item Center for Epidemiologic Studies—Depression Scale. Negative
binomial regression was used to compare the number of depressive symptoms between adults with and
without diabetes in each quartile of diabetes care quality. Analyses included adjustment for covariates and
survey weights. Results: In countries with the highest quality of diabetes care, having diabetes was associated
with only a 3% relative increase in depressive symptoms (95% CI 1.00–1.05). In countries in the second, third and
fourth (lowest) quartiles of diabetes care quality, having diabetes was associated with a 13% (95% CI 1.08–1.17),
13% (1.08–1.19) and 22% (1.14–1.31) relative increase in depressive symptoms, respectively. Conclusion: The as-
sociation between diabetes and depressive symptoms appears stronger in European countries with lower quality
of diabetes care. Potential pathways for this association include the financial aspects of diabetes care, access to
services and differential exposure to the social determinants of heath. Further research is needed to unpack these
mechanisms and improve the quality of life of people with diabetes across Europe.
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Introduction
Diabetes is highly prevalent in European adults, with a prevalenceof approximately 10.3% of men and 9.6% of women.1
Depression among people with diabetes is associated with poorer
diabetes control and treatment adherence,2 increased diabetes com-
plications,3 and a higher risk of mortality.4 Although it is generally
accepted that depression or its symptoms are twice as prevalent
among people with diabetes, estimates vary across Europe.5,6 In a
UK study, 5.0% of participants with diabetes had possible cases of
depression compared with 3.8% without diabetes.7 In a large city in
the Netherlands, 29.7% of participants with diagnosed diabetes
reported elevated depressive symptoms, in contrast to 19.4% of par-
ticipants with normal glucose levels.8
The relationship between diabetes and depression may be partially
attributable to the physical and psychological burden of managing
diabetes and its complications.9 This burden may include financial
difficulties due to diabetes expenses, effects of social stigma or un-
employment as a result of ill health.10–12 People with diabetes may
also experience stress from the daily psychological burden of
monitoring dietary intake, physical activity levels and blood sugar
levels.9,13 The burden of disease hypothesis is supported by cross-
sectional evidence that diagnosed diabetes is more strongly
associated with depression than undiagnosed diabetes.8,14 As well,
having diagnosed diabetes is associated with an approximate 27%
increased risk of new-onset depression compared with not having
diabetes.9
Notably, the stress associated with diabetes may differ based on
quality of diabetes care. Better quality of care may reduce the
financial, social or psychological burden of diabetes and result in
reduced depressive symptoms. However, very little evidence is
available to evaluate this hypothesis. One study conducted in the
USA found that less availability or affordability of diabetes
medication and supplies was associated with increased diabetes-
related psychological stress.15 Another study looked at differences
in depressive symptoms between people with diabetes living on
either side of the USA/Mexico border, which have differing levels
of quality of health care.16 No differences in depressive symptoms
were observed between groups.16 However, participants in this study
were selected from a convenience sample and diabetes care quality
was not measured in detail.16
Further cross-national research is warranted to better elucidate
associations between diabetes, depression and diabetes care quality
in non-USA settings using large samples and robust measures of
quality of diabetes care. A large proportion of the research on
depression and diabetes has been conducted in the USA and may
not apply to European populations where healthcare systems
generally provide more universal access, also termed higher levels
of healthcare decommodification.17 This study aims to assess
whether the association between diabetes and depressive symptoms
differs by quality of diabetes care across 19 European countries. It is
hypothesized that this relationship will be weaker in countries with
higher standards of diabetes care.
Methods
Data
Data come from the European Social Survey (ESS), a repeated cross-
sectional survey of social attitudes and values in 21 countries across
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Europe.18,19 This analysis used Round 7 of the ESS (ESS7), as this
was the first time detailed information was collected on health
conditions, lifestyle behaviours and the social determinants of
health.18 Each country in ESS7 used random probability sampling
to select a representative sample of individuals aged 15 and over in
private households, though specific sampling methods varied by
country.18 Sampling was completed between August 2014 and
December 2015 and several attempts were made to contact initial
non-respondents.18 The mean response rate was 56% across all ESS7
countries and ranged from 31% in Germany to 69% in Lithuania.20
This study included all adult participants (age 18+) from ESS7
countries except Estonia, as it did not collect information on
depressive symptoms, and Israel, as it is not located geographically
in Europe. All survey data and documentation are freely available at
www.europeansocialsurvey.org.
Measures
Self-reported depressive symptoms were measured using the 8-item
Center for Epidemiologic Studies—Depression Scale (CESD-8).
Depressive symptoms included feeling depressed, not feeling
happy, feeling lonely, not enjoying life, feeling sad, feeling that
everything was an effort, feeling that you could not get going, and
sleeping problems. Participants indicated how much of the time
during the past week they endorsed each symptom on a 4-point
scale (never, some of the time, most of the time or all or almost
all of the time). The CESD-8 supports a single factor structure,21 and
a final depressive symptom score was created by summing partici-
pants’ responses for each symptom. Possible scores ranged from 0
(no symptoms) to 32 (all symptoms present nearly all the time).
Diabetes was measured in the ESS by asking participants whether
they had or had experienced diabetes in the past 12 months. Self-
reported diabetes has a high sensitivity in Europe when compared
with medical records, reported medication or repeated self-report of
diabetes (sensitivity = 0.79).22
Quality of diabetes care was measured using the Euro Diabetes
Index (EDI) 2014 published by Healthcare Consumer Powerhouse.23
The EDI was developed by an expert panel of clinicians and
academics to compare European healthcare systems and services.23
Indicators of quality of care included diabetes prevention initiatives,
case finding and screening, range and reach of services (e.g. eye care,
pharmaceuticals availability), access to treatment or care (e.g. patient
education, coverage of diabetes supplies), procedures available
(e.g. annual blood tests, eye exams) and diabetes outcomes.23
Information for each indicator was obtained from national and
international surveys (e.g. WHO World Health Statistics),
interviews with health care workers and public health experts, and
national and regional diabetes registries, programs and reports.23
A total score for each country was calculated using a weighted
sum of these indicators.23 Scores ranged from 509 in Lithuania to
946 in Sweden, with a maximum possible score of 1000.23
Importantly, a country’s relative position is more indicative of
their quality of care than to their absolute score or ranking and
therefore countries were divided into quartiles of quality of care
for this analysis.23
Covariates included age in years, sex, education, marital status,
current feeling about household income and employment (see
table 1). Clinical covariates included the presence of heart/circula-
tion problems (e.g. stroke) or high blood pressure in the past
12 months as well as body mass index (BMI) calculated from self-
reported height and weight. The continuous covariates age and BMI
were modelled using fractional polynomial models to account for
non-linearly, which select the best higher-order terms for each
covariate (e.g. age squared). Self-reported lifestyle covariates
including smoking status, alcohol consumption and engagement in
physical activity.
Sample size
A total of 34 467 adults participated in ESS7 from the 19 studies
included in this analysis. Those with a self-reported height of 110 cm
or below were excluded, as this may be due to measurement error
and obesity measures for these participants were extremely high
(n= 17). Of the remaining sample, 91% had complete information
on all variables. Most participants with incomplete information were
missing BMI values (n= 1113), presence of heart/circulation
problems (n= 594) or physical activity levels (n= 383). Missing
demographic, clinical and lifestyle variables were imputed using
ordered logistic regression (education level, satisfaction with
current income, number of days of physical activity), multinomial
logistic regression (sex, presence of heart problems or diabetes,
marital status, smoking status, alcohol consumption) or linear
regression (age, BMI) regression with all other variables as
predictors. As well, approximately 2.2% of the sample had missing
information on at least one depressive symptom (n= 752).
Depressive symptoms were imputed using ordered logistic
regression on all other depressive symptoms as well as the demo-
graphic and clinical characteristics listed above. Twenty complete
imputed datasets were created. The final sample included34 420
participants who had complete information following multiple
imputation.
Statistical analysis
The outcome of total number of depressive symptoms was modelled
using negative binomial regression in order to reflect the positively
skewed distribution of depressive symptoms in the European
population. Presence of diabetes, diabetes quality of care quartile
and an interaction term were included as predictors. A non-zero
interaction term would indicate that the association between
diabetes and depression varies depending on the quartile of
diabetes care quality. Sensitivity analyses examined the same associ-
ations by sex and education level. Standard error estimates
incorporated clustering by country as well as variance from
multiply imputed datasets. Sampling weights were used in all
analyses to account for (i) selection probabilities of each participant
based on each country’s sampling design and (ii) sampling error and
non-response based on age, gender, education and region.24
Population weights were applied to account for differences in the
population size of each country.24 All analyses were conducted using
Stata version 12 and used a significance level of 0.05.
Results
The highest quality of diabetes care was observed in Nordic
countries, while lower quality of care was more prevalent in
Eastern Europe (table 1). This is consistent with trends observed
in overall healthcare in European countries in the same year,
albeit with some discrepancies.25 Country rankings are also
somewhat consistent with Bohm et al.’s classification of health
care systems based on health care regulation, financing and service
provision.26 Countries with National Health Service or National
Health Insurance systems (healthcare regulation and financing by
the state) include Denmark, Finland, Norway, Sweden, Portugal,
Spain, the UK and Ireland.26 While the majority of these countries
rank at top of quality of diabetes care, Spain, Portugal and Ireland
have lower quality of diabetes care. Countries with Social Health
Insurance systems, or regulation and financing by non-governmen-
tal organizations, include Austria, Germany, Switzerland and
Slovenia.26 These countries generally had quality of care rankings
in the second or third quartiles. Belgium, France, the Czech
Republic, Hungary, the Netherlands and Poland have a mix of
state, social and private healthcare regulation, financing and provi-
sion.26 Countries with this system were found in all quartiles of
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diabetes care. Country-specific scores are presented in
Supplementary table S1.23
Table 1 presents differences in demographic, lifestyle and clinical
factors between quartiles. The mean age of participants varied from
44.2 years (quartile 4)–49.2 years (quartile 2). There were approxi-
mately equal proportions of men and women in each quartile. Over
half of participants in all quartiles were married, in a partnerships or
cohabitating. Under 10% of the population in quartiles 1, 2 and 4
were unemployed or permanently sick/disabled, while nearly 13% of
participants in the 3rd quartile were unemployed. Education levels
were highest in the first and second quartiles and lowest in the third.
Satisfaction with income followed a decreasing trend by quartile of
care. Smoking trends were similar between quartiles, with 22 to 28%
of the population as current smokers. Frequency of alcohol con-
sumption decreased from higher to lower quartiles, and physical
activity was highest in the first quartile and lowest in the third.
BMI did not differ between quartiles. Patterns of heart or circulation
problems, diabetes and mean number of depressive symptoms
varied by quartile with no clear trend.
Results from the negative binomial regression model are shown in
table 2 as the ratio of depressive symptoms between people with
diabetes compared with those without diabetes by quartile of
diabetes care quality. Having diabetes was associated with
increased depressive symptoms across all quartiles. Adjustment
for demographic, clinical and lifestyle characteristics attenuated
these associations, though they were still statistically significant.
The association between diabetes and depressive symptoms
increased as quality of diabetes care decreased. In the fully
adjusted model, statistically significant differences in depressive
symptoms associated with diabetes are observed between the first
(highest) quartile of diabetes care and all other quartiles and between
the second and fourth quartiles (figure 1).
Figure 2 presents the main analysis stratified by sex. Men with
diabetes in countries in the highest quartile of diabetes care showed
no increased depressive symptoms, but higher depressive symptom
scores were observed in men with diabetes in the second, third and
fourth quartiles. In women, diabetes was associated with increased
depressive symptoms even in countries with the highest quality of
diabetes care, but differences between quartiles were not statistically
significant. A similar pattern of increasing depressive symptoms
among people with diabetes in lower quartiles of diabetes care was
observed in each level of education (Supplementary figure S1).
Discussion
The results of this analysis suggest that diabetes is more strongly
related to depressive symptoms in European countries with poorer
quality of diabetes care. While diabetes was associated with an
increased rate of depressive symptoms across all levels of diabetes
care quality, this association was weakest in countries with the
highest quality of care (RR = 1.03, 95% CI 1.00–1.05) and
strongest is countries with the poorest quality of diabetes care
Table 1 Demographic, clinical and lifestyle characteristics of participants in the European social survey 7 by quartile of diabetes care quality




Quartile 2 Quartile 3 Quartile 4
(lowest)
N=8719 N=9362 N=8211 N=8128




















Age mean (SD) 47.4 (0.30) 49.2 (0.32) 47.5 (0.29) 44.4 (0.32)
% Female 51.6 51.9 51.9 52.4
Marital status
Married/civil partnership/cohabitating 53.0 56.0 49.6 56.9
Divorced/separated/widowed 15.3 15.6 16.6 13.7
Never Married 31.7 28.4 33.8 29.4
Main activity
Employed, retired, housework, other 91.3 91.1 86.9 92.3
Unemployed 4.9 6.3 10.0 6.7
Sick/disabled 3.7 2.6 3.0 0.9
Education
Primary or lower secondary 30.3 30.4 55.2 35.6
Secondary 45.5 56.8 30.3 46.2
Tertiary 24.1 12.8 14.4 18.1
Income feeling
Living comfortably 45.1 32.4 23.8 12.3
Coping on present income 39.6 50.9 46.7 61.5
Difficult on present income 11.8 13.5 21.7 22.3
Very difficult on present income 3.5 3.1 7.8 3.9
BMI mean(SD) 25.8 (0.08) 25.8 (0.09) 25.7 (0.07) 25.7 (1.00)
% Heart/circulation problems or high blood pressure in past 12 months 3.9 6.1 5.0 7.1
% Diabetes in past 12 months 5.0 6.4 5.3 4.2
Total depressive symptoms mean(SD) 4.9 (0.06) 5.4 (0.07) 6.1 (0.07) 5.4 (0.09)
Smoking
Current 22.5 29.3 28.6 28.3
Former 25.4 23.6 19.9 18.9
Never 52.1 47.1 51.4 52.7
Alcohol use in past 12 months
Never 17.3 16.1 27.6 21.7
Once a month or less 20.4 22.5 19.7 34.5
Once a week or less 31.2 34.1 26.3 31.9
Every day or several times a week 31.0 27.3 26.4 11.8
Number of past 7 days did sports or other physical activity mean(SD) 3.4 (0.04) 3.1 (0.05) 2.8 (0.04) 3.0 (0.05)
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(RR = 1.22, 95% CI 1.14–1.31). These results suggest that improved
quality of diabetes care may reduce some of the psychological
burden associated with living with diabetes.
These results are consistent with interventions that have reported
improved depression scores in participants who received increased
diabetes monitoring, education or prevention. One trial showed that
people with Type 2 diabetes who used a glucose-monitoring device,
kept a diary of glucose levels and intake, and received counselling
experienced an improvement in depressive symptoms.27 Those who
only received general counselling about their diet and lifestyle did
not.27 Another trial showed that the implementation of a diabetes
prevention program was associated with a decrease in depressive
symptoms in the intervention group compared with the control
group.28 The authors of both trials suggest that decreased
depressive symptoms may be related to a heightened sense of
control over diabetes.27,28 However, a meta-analysis of web-based
interventions that promoted better diabetes care did not show that
such interventions were associated with decreased depression.29
Further analyses in this study examined associations between
diabetes and depressive symptoms comparing men and women. In
countries with poorer quality of care, men showed a stronger asso-
ciation between diabetes and depression than women. This is
consistent with previous meta-analyses that report sex-specific asso-
ciations.6,14 This may be partially attributable to women’s greater use
of diabetes-related healthcare services, higher adherence to glucose
monitoring and selfcare, or increased social support.30–33 However,
in countries with the highest quality of care, diabetes was not
associated with increased depressive symptoms in men but there
was an association in women. This may allude to an added
burden of managing diabetes in addition to childcare and family
responsibilities, which are largely the role of women in all
European countries.34 Women also report more health conditions
and diabetes complications than men, such as poorer physical func-
tioning, higher cholesterol levels, and more diabetes-related compli-
cations, which may contribute to increased depressive
symptoms.30,35 Similar to the main results, analyses stratified by
educational status suggest that lower quality of diabetes care is
associated with higher depressive symptoms across all educational
levels. As well, higher educational levels appear to be associated with
fewer depressive symptoms in diabetes in countries with higher
Table 2 Rate ratio of diabetes on depressive symptoms by diabetes quartile
Quality of diabetes care Model 1 Model 2 Model 3
Quartile 1 1.19 1.16–1.22 1.05 1.03–1.09 1.03 1.00–1.05
Quartile 2 1.37a 1.33–1.41 1.14a 1.11–1.17 1.13a 1.08–1.17
Quartile 3 1.33a 1.25–1.42 1.16a 1.10–1.21 1.13a 1.08–1.19
Quartile 4 1.53a,c 1.36–1.71 1.26a,b 1.15–1.39 1.22a,b 1.14–1.31
Rate ratios estimated from a negative binomial regression model of diabetes, quartile of diabetes care and their interaction on number of
depressive symptoms.
Model 1: unadjusted. Model 2: adjusted for individual differences in age, education, education  diabetes care quartile, satisfaction with
income, gender, marital status, employment status, BMI and heart/circulation problems or high blood pressure. Model 3: additionally
adjusted for smoking, alcohol use, alcohol use  diabetes care quartile and number of days doing physical activity.
a: Significantly different from Quartile 1.
b: Significantly different from Quartile 2.
c: Significantly different from Quartile 3.
Figure 1 Percentage (%) increase in number of depressive symptoms in people with diabetes versus without diabetes. Estimates adjusted
for age, sex, education level, marital status, current feeling about household income, employment status, presence of heart/circulation
problems or high blood pressure, body mass index, smoking status, alcohol consumption and physical activity
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levels of quality of care, consistent with prior research.36 This may be
due to more positive attitudes towards diabetes and better coping
strategies among those with more education.36
Of course, quality of care is only possible pathway linking diabetes
with an increased risk of depression. Our findings might therefore
also reflect wider issues within the welfare or health care systems or
indeed other individual factors such as the social stigma related to
diabetes. However, by controlling for lifestyle factors and socio-
demographics, we hope to have taken into account some of these
wider issues and isolated the role of quality of care.
Strengths
This is the first nationally comparative study of depressive symptoms
and diabetes across Europe and provides novel evidence on quality
of diabetes care and psychological symptoms associated with
diabetes. This analysis used a large, representative dataset of partici-
pants in 19 European countries. The ESS7 ensured representative-
ness though methods such as strict probability sampling and re-
contacting initial non-respondents.18 As well, survey weighting and
multiple imputation of missing variables were used in this analysis to
minimize potential bias from selection of participants and non-
response. Due to the number of countries included, comparisons
were possible between different levels of quality of diabetes care
using an objective, international measure.
Limitations
Limitations of this study include uncertainty in the temporal order
of diabetes and depressive symptoms, as the dataset was cross-
sectional. Consequently, causality cannot be inferred. Unmeasured
confounding may be present due to differences in mental health care
across Europe. However, there are currently no tools available that
allow a detailed comparative assessment of mental health care across
Europe. Unmeasured confounding may also be present on an
individual level from diabetes complications that were not
measured the European Social Survey.37 This analysis was also
unable to differentiate between Type 1 and Type 2 diabetes,
although elevated depressive symptoms are associated with both
types of diabetes in European populations.38
Diagnosed diabetes was assessed using self-reported measures and
may have been underestimated. Yet validation studies suggest that
self-reported diagnosed diabetes has high concordance with
physician records or antidiabetic drug use.39,40 Furthermore, mis-
classification of diabetes would bias the association between diabetes
and depressive symptoms towards the null.
Finally, quality of diabetes care may differ substantially within a
country, and the measure used in this study does not capture
regional or local granularity. The authors of the Euro Diabetes
Index acknowledge this limitation, but suggest that this index may
nonetheless be meaningful when interpreted with caution.23 Further
research should consider more local measures of quality of diabetes
care.
Conclusions
Results suggest an inverse association between national quality of
diabetes care and depressive symptoms among people with diabetes.
In countries with high quality of diabetes care, diabetes was
associated with a small increase in depressive symptoms while
countries with poorer quality of care showed a larger increase in
depressive symptoms among people with diabetes. This association
persisted when adjusted for individual demographic, clinical and
behavioural characteristics. Quality of diabetes care may therefore
be important not only for physical complications of diabetes but also
for depressive symptoms and psychosocial outcomes.
Supplementary data
Supplementary data are available at EURPUB online.
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Key points
 Diabetes is associated with increased depressive symptoms
across Europe
 An increased association between diabetes and depressive
symptoms was observed in countries with lower quality of
diabetes care compared with those with higher quality of
diabetes care
 Higher quality of diabetes care may reduce the burden or
stress of disease and is associated with fewer depressive
symptoms among adults with diabetes
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